Literature DB >> 20960482

Nonlinear decline of mini-mental state examination in Parkinson's disease.

Dag Aarsland1, Graciela Muniz, Fiona Matthews.   

Abstract

The trajectory of cognitive functioning in patients with Parkinson's disease (PD) is not known. We used a random change point model to study the individual cognitive trajectory for up to 15 years in a prevalence sample of 238 PD patients, and used the mini-mental state examination (MMSE) to assess the longitudinal cognitive course. We observed that the rate of global cognitive decline was nonlinear. Following a relatively stable period, an inflection point was identified, after which the rate of decline gained momentum with an annual decline of 2.8 points on the MMSE. The course was similar in men and women. This inflection point was estimated to occur 13.3 years (95% credible interval 11.8, 13.6) after the diagnosis of PD; however, there were wide interindividual variations in the time from onset of PD to the inflection point.
Copyright © 2010 Movement Disorder Society.

Entities:  

Mesh:

Year:  2010        PMID: 20960482     DOI: 10.1002/mds.23416

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  19 in total

1.  Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson's disease.

Authors:  Han-Joon Kim; Beom S Jeon; Sun Ha Paek; Kyoung-Min Lee; Ji-Young Kim; Jee-Young Lee; Hee Jin Kim; Ji Young Yun; Young Eun Kim; Hui-Jun Yang; Gwanhee Ehm
Journal:  J Neurol       Date:  2014-04-01       Impact factor: 4.849

2.  When does cognitive decline begin? A systematic review of change point studies on accelerated decline in cognitive and neurological outcomes preceding mild cognitive impairment, dementia, and death.

Authors:  Justin E Karr; Raquel B Graham; Scott M Hofer; Graciela Muniz-Terrera
Journal:  Psychol Aging       Date:  2018-03

3.  Deep brain stimulation and cognitive decline in Parkinson's disease: The predictive value of electroencephalography.

Authors:  A Markser; Franziska Maier; C J Lewis; T A Dembek; D Pedrosa; C Eggers; L Timmermann; E Kalbe; G R Fink; Lothar Burghaus
Journal:  J Neurol       Date:  2015-07-11       Impact factor: 4.849

Review 4.  MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Authors:  Irene Litvan; Dag Aarsland; Charles H Adler; Jennifer G Goldman; Jaime Kulisevsky; Brit Mollenhauer; Maria C Rodriguez-Oroz; Alexander I Tröster; Daniel Weintraub
Journal:  Mov Disord       Date:  2011-06-09       Impact factor: 10.338

Review 5.  Mild cognitive impairment in Parkinson's disease.

Authors:  Dag Aarsland; Kolbjørn Brønnick; Tormod Fladby
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

6.  MMSE and MoCA in Parkinson's disease and dementia with Lewy bodies: a multicenter 1-year follow-up study.

Authors:  Roberta Biundo; L Weis; S Bostantjopoulou; E Stefanova; C Falup-Pecurariu; M G Kramberger; G J Geurtsen; A Antonini; D Weintraub; D Aarsland
Journal:  J Neural Transm (Vienna)       Date:  2016-02-06       Impact factor: 3.575

Review 7.  Is all cognitive impairment in Parkinson's disease "mild cognitive impairment"?

Authors:  Saül Martínez-Horta; Jaime Kulisevsky
Journal:  J Neural Transm (Vienna)       Date:  2011-06-22       Impact factor: 3.575

8.  Parkinson's disease disrupts both automatic and controlled processing of action verbs.

Authors:  Leonardo Fernandino; Lisa L Conant; Jeffrey R Binder; Karen Blindauer; Bradley Hiner; Katie Spangler; Rutvik H Desai
Journal:  Brain Lang       Date:  2012-08-19       Impact factor: 2.381

Review 9.  A review of disease progression models of Parkinson's disease and applications in clinical trials.

Authors:  Charles S Venuto; Nicholas B Potter; E Ray Dorsey; Karl Kieburtz
Journal:  Mov Disord       Date:  2016-05-26       Impact factor: 10.338

10.  Conditioning Against the Pathology of Parkinson's disease.

Authors:  Rehana K Leak
Journal:  Cond Med       Date:  2018-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.